Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTrellus Health. Regulatory News (TRLS)

  • This share is currently suspended. It was suspended at a price of 0.12

Share Price Information for Trellus Health. (TRLS)

Share Price is delayed by 15 minutes
Get Live Data
0.12    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: £516.14k
TRLS Live PriceLast checked at - London Stock Exchange

Intraday Trellus Health. Share Chart

Holding(s) in Company

26 Feb 2026 15:08

RNS Number : 5862U
Trellus Health PLC
26 February 2026
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

Trellus Health plc

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

X

Other (please specify)iii:

3. Details of person subject to the notification obligationiv

Name

Unicorn Asset Management Limited

City and country of registered office (if applicable)

London, United Kingdom

4. Full name of shareholder(s) (if different from 3.)v

Name

Unicorn AIM VCT plc

City and country of registered office (if applicable)

Teignmouth, Devon, United Kingdom

5. Date on which the threshold was crossed or reachedvi:

25 February 2026

6. Date on which issuer notified (DD/MM/YYYY):

26 February 2026

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer (8.A + 8.B) vii

Resulting situation on the date on which threshold was crossed or reached

2.99%

2.99%

6,250,000

Position of previous notification (if

applicable)

3.87%

3.87%

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Ordinary shares GB00BNNFM402

6,250,000

2.99%

SUBTOTAL 8. A

6,250,000

2.99%

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

SUBTOTAL 8. B 1

 

 

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

 

SUBTOTAL 8.B.2

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

X

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

 

10. In case of proxy voting, please identify:

Name of the proxy holder

See Section 4

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional informationxvi

Figures are based on total voting rights of 208,719,361

 

Place of completion

Unicorn Asset Management Limited, Preachers Court, Charterhouse, Charterhouse Square, London, EC1M 6AU

Date of completion

26 February 2026

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLEASAKAEXKEFA
Date   Source Headline
8th May 20267:30 amRNSSuspension - Trellus Health Plc
8th May 20267:00 amRNSUpdate on Funding & Suspension of Trading
28th Apr 20267:00 amRNSIssue of Equity - Conversion of Loan Notes
15th Apr 20267:00 amRNSIssue of Equity - Conversion of Loan Notes
13th Apr 20267:00 amRNSPfizer Licensing Agreement Renewal
8th Apr 20267:00 amRNSIssue of Equity - Conversion of Loan Notes
2nd Apr 20267:00 amRNSFunding Update
27th Mar 20267:00 amRNSMSA Signed and Funding Update
18th Mar 202612:29 pmRNSIssue of Equity - Conversion of Loan Notes
13th Mar 20268:45 amRNSHolding(s) in Company
13th Mar 20268:45 amRNSHolding(s) in Company
13th Mar 20268:43 amRNSHolding(s) in Company
13th Mar 20268:43 amRNSHolding(s) in Company
10th Mar 20267:01 amRNSHolding(s) in Company
10th Mar 20267:01 amRNSHolding(s) in Company
10th Mar 20267:00 amRNSIssue of Equity - Conversion of Loan Notes
2nd Mar 20267:00 amRNSIssue of Equity - Conversion of Loan Notes
26th Feb 20263:08 pmRNSHolding(s) in Company
23rd Feb 20267:00 amRNSIssue of Equity
18th Feb 20267:05 amRNSContract Extension with Johnson & Johnson
18th Feb 20267:00 amRNSIssue of Equity - Conversion of Loan Notes
11th Feb 20267:00 amRNSIssue of Equity
6th Feb 202610:45 amRNSHolding(s) in Company
3rd Feb 20265:37 pmRNSHolding(s) in Company
3rd Feb 20265:31 pmRNSHolding(s) in Company
3rd Feb 20267:00 amRNSBusiness update
29th Jan 20267:00 amRNSGrant of Share Options
22nd Jan 20267:00 amRNSHolding(s) in Company
20th Jan 20262:00 pmRNSResult of Meeting
19th Jan 20267:00 amRNSGrant of Share Options
30th Dec 20255:00 pmRNSProposed issue of Secured Convertible Loan Notes
30th Dec 20255:00 pmRNSProposed issue of Secured Convertible Loan Notes
24th Nov 20257:00 amRNSFinance update
7th Nov 20257:00 amRNSContract signed with second leading CRO
22nd Oct 20257:00 amRNSContract Signed with Leading Global CRO
21st Oct 20257:00 amRNSCompany Update
8th Sep 20253:15 pmRNSInterim results - Replacement
8th Sep 20257:00 amRNSInterim results
3rd Sep 20257:00 amRNSNotice of Results
12th Aug 20257:00 amRNSHolding(s) in Company
1st Jul 20257:00 amRNSResult of AGM
30th Jun 20257:00 amRNSAGM Statement
4th Jun 20257:00 amRNSPosting of Annual Report and Notice of AGM
2nd Jun 20257:00 amRNSFinal Results
23rd Apr 20254:30 pmRNSGrant of Share Options
4th Mar 20257:00 amRNSBusiness update
14th Jan 20257:00 amRNSAgreement with Johnson & Johnson
27th Dec 202410:30 amRNSChange of Registered Office
30th Sep 20247:00 amRNSHolding(s) in Company
26th Sep 20247:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.